H. Navabi

2.0k total citations
18 papers, 1.7k citations indexed

About

H. Navabi is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, H. Navabi has authored 18 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in H. Navabi's work include Immunotherapy and Immune Responses (8 papers), Extracellular vesicles in disease (3 papers) and Trace Elements in Health (3 papers). H. Navabi is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Extracellular vesicles in disease (3 papers) and Trace Elements in Health (3 papers). H. Navabi collaborates with scholars based in United Kingdom, Germany and France. H. Navabi's co-authors include Bharat Jasani, Aled Clayton, Malcolm D. Mason, Malcolm Adams, Zsuzsanna Tabi, Jan A. Hobot, John Morgan, Jacquelyn Court, Kurt Werner Schmid and A R Gibbs and has published in prestigious journals such as Journal of Cell Science, Thorax and European Journal of Cancer.

In The Last Decade

H. Navabi

18 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Navabi United Kingdom 12 1.1k 511 386 263 161 18 1.7k
Curtis Ruegg United States 17 911 0.8× 738 1.4× 308 0.8× 274 1.0× 103 0.6× 29 1.7k
Jean-Michel Escola France 10 1.3k 1.2× 600 1.2× 389 1.0× 140 0.5× 175 1.1× 13 2.0k
Stefanie Mandl United States 14 789 0.7× 234 0.5× 323 0.8× 442 1.7× 118 0.7× 25 1.4k
Santosh K. Patnaik United States 25 1.5k 1.4× 328 0.6× 788 2.0× 321 1.2× 129 0.8× 43 2.1k
Ben Quah Australia 19 722 0.6× 1.0k 2.0× 174 0.5× 237 0.9× 140 0.9× 33 1.8k
Catherina H. Bird Australia 20 908 0.8× 950 1.9× 413 1.1× 319 1.2× 240 1.5× 33 2.1k
Jeff D. Colbert United States 18 804 0.7× 944 1.8× 240 0.6× 526 2.0× 167 1.0× 20 1.8k
Timo Burster Germany 23 510 0.5× 677 1.3× 293 0.8× 201 0.8× 147 0.9× 73 1.4k
Jonathan P. Butchar United States 28 1.1k 1.0× 1.0k 2.0× 278 0.7× 424 1.6× 148 0.9× 58 2.3k
Helen C. O’Neill Australia 25 699 0.6× 1.3k 2.6× 174 0.5× 246 0.9× 96 0.6× 123 2.2k

Countries citing papers authored by H. Navabi

Since Specialization
Citations

This map shows the geographic impact of H. Navabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Navabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Navabi more than expected).

Fields of papers citing papers by H. Navabi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Navabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Navabi. The network helps show where H. Navabi may publish in the future.

Co-authorship network of co-authors of H. Navabi

This figure shows the co-authorship network connecting the top 25 collaborators of H. Navabi. A scholar is included among the top collaborators of H. Navabi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Navabi. H. Navabi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Jasani, Bharat, H. Navabi, & Malcolm Adams. (2009). Ampligen: A potential toll-like 3 receptor adjuvant for immunotherapy of cancer. Vaccine. 27(25-26). 3401–3404. 114 indexed citations
2.
Navabi, H., Bharat Jasani, Ashley Reece, et al.. (2008). A clinical grade poly I:C-analogue (Ampligen®) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro. Vaccine. 27(1). 107–115. 106 indexed citations
3.
Navabi, H., Jan A. Hobot, Aled Clayton, et al.. (2005). Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial. Blood Cells Molecules and Diseases. 35(2). 149–152. 95 indexed citations
4.
Clayton, Aled, et al.. (2005). Induction of heat shock proteins in B-cell exosomes. Journal of Cell Science. 118(16). 3631–3638. 344 indexed citations
5.
Rhodes, Anthony, Bharat Jasani, Jérôme Couturier, et al.. (2002). A Formalin-Fixed, Paraffin-Processed Cell Line Standard for Quality Control of Immunohistochemical Assay of HER-2/neu Expression in Breast Cancer. American Journal of Clinical Pathology. 117(1). 81–89. 74 indexed citations
6.
Adams, Malcolm, Leszek K. Borysiewicz, Alison Fiander, et al.. (2001). Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer. Vaccine. 19(17-19). 2549–2556. 93 indexed citations
7.
Clayton, Aled, Jacquelyn Court, H. Navabi, et al.. (2001). Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. Journal of Immunological Methods. 247(1-2). 163–174. 466 indexed citations
8.
Adams, Malcolm, Alison Fiander, Stephen Man, et al.. (2001). Clinical studies of human papilloma vaccines in cervical cancer. Advances in experimental medicine and biology. 495. 419–427. 9 indexed citations
10.
Gibbs, A R, Bharat Jasani, Chris Pepper, H. Navabi, & David Wynford‐Thomas. (1998). SV40 DNA sequences in mesotheliomas.. PubMed. 94. 41–5. 3 indexed citations
11.
Jasani, Bharat, Fiona Campbell, H. Navabi, Kurt Werner Schmid, & Geraint T. Williams. (1998). Clonal overexpression of metallothionein is induced by somatic mutation in morphologically normal colonic mucosa. The Journal of Pathology. 184(2). 144–147. 35 indexed citations
12.
Jasani, Bharat, Fiona Campbell, H. Navabi, Kurt Werner Schmid, & Geraint T. Williams. (1998). Clonal overexpression of metallothionein is induced by somatic mutation in morphologically normal colonic mucosa. The Journal of Pathology. 184(2). 144–147. 2 indexed citations
13.
Navabi, H., Bharat Jasani, Malcolm Adams, et al.. (1997). Generation of in Vitro Autologous Human Cytotoxic T-Cell Response to E7 and HER-2/Neu Oncogene Products Using Ex-Vivo Peptide Loaded Dendritic Cells. Advances in experimental medicine and biology. 417. 583–589. 9 indexed citations
14.
Morgan, John, H. Navabi, & Bharat Jasani. (1997). ROLE OF CALCIUM CHELATION IN HIGH-TEMPERATURE ANTIGEN RETRIEVAL AT DIFFERENT pH VALUES. The Journal of Pathology. 182(2). 233–237. 49 indexed citations
15.
Douglas-Jones, Anthony, H. Navabi, John Morgan, & Bharat Jasani. (1997). Immunoreactive p53 and metallothionein expression in duct carcinoma in situ of the breast. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 430(5). 373–379. 17 indexed citations
16.
Pepper, Chris, Bharat Jasani, H. Navabi, David Wynford‐Thomas, & A R Gibbs. (1996). Simian virus 40 large T antigen (SV40LTAg) primer specific DNA amplification in human pleural mesothelioma tissue.. Thorax. 51(11). 1074–1076. 80 indexed citations
17.
Morgan, John, H. Navabi, Kurt Werner Schmid, & Bharat Jasani. (1994). Possible role of tissue‐bound calcium ions in citrate‐mediated high‐temperature antigen retrieval. The Journal of Pathology. 174(4). 301–307. 151 indexed citations
18.
Jasani, Bharat, Norman D. Thomas, H. Navabi, et al.. (1992). Dinitrophenyl (DNP) hapten sandwich staining (DHSS) procedure. Journal of Immunological Methods. 150(1-2). 193–198. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026